A discussion of early-stage investments on the global stage. Have the strategies for fundraising changed due to Covid-19? What should early-stage companies do to better attract global investors at this time? What recommendations do panelists have for start-ups to weather through the Covid-19 storm from fundraising, global expansion, and partnership perspectives.
This panel will feature 4 speakers and a moderator. Questions include, but not limited to:
- What is the current investment thesis in healthcare during and post Covid-19?
- What are the major differences in the life science industry between US/Europe and Asia from an investment perspective?
- What global investment and partnership trends do you see in your geography and/or sector?
What suggestions do you have for founders/companies to reach out to international investors, especially at this “special” time we are in?